Gilead Gets Buy, Amgen Holds: Biopharma Calls Roil Markets
Wall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
Understanding what a beginner investment portfolio looks like is crucial for new investors. Learn the basics to kickstart your investment journey.
27,003 articlesWall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
Visionary Homes has announced that Ryan Smith will become CEO on Sept. 1, 2026, with founder Jeff Jackson moving to c...
Hims & Hers Health shifts to selling branded Wegovy and Ozempic after a settlement with Novo Nordisk, reversing regul...
Jim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
In 2026, a disciplined trio of growth ETFs offers a clear path to long-term wealth through earnings-driven expansion,...
Gold retreats while Bitcoin-focused ETFs keep drawing capital, highlighting a widening split in how investors price i...
Move, operator of Realtor.com, delivered a 10% year‑over‑year revenue gain in News Corp’s Q3 results. The broader com...
A billionaire investor backed D-Wave Quantum in late 2024, and the stock has surged and slumped in a choppy 2026 trad...
Markets are buzzing about a downturn, but the latest data suggests reacting to headlines may hurt more than help. Thi...
A 60-year-old with $900k faces a five-year health-insurance gap before Medicare, risking six figures if subsidies are...
CoinW launches TradFi, a cross-market upgrade that folds traditional assets into perpetual crypto contracts. The move...
A surprising rally in small-cap value equities challenges the usual price-pressures from inflation and higher rates. ...